Eschborn – In addition to COVID-19, others may
viral respiratory infections cause chronic lung damage. In an ongoing study, researchers from the University of St. Louis / USA have been able to determine possible pathomechanisms that could be responsible for such lung damage after viral respiratory infections.. In order to curb the development of acute respiratory tract infections and possible associated tissue damage as early as possible, phytotherapeutic agents are suitable, which support the body in the fight against infections thanks to their antiviral and anti-inflammatory properties. . These are, for example, mustard oils based on nasturtium and horseradish (ANGOCIN® anti-infective NOT), which is not only antiviral[2-4]but also antibacterial[5-7] and anti-inflammatory[8-13] works. “Mustard oils should preferably be used at the first signs of a cold,” says doctor of integrative medicine, medical Dr. Christoph Daniel Hohmann, Traunstein. “By taking these herbal active ingredients as early as possible, acute respiratory infections can be nipped in the bud,” continues Hohmann. The combination of nasturtium and horseradish also shortens the duration of rhinosinusitis infection by two days and reduces the risk of another cold by around 50% when taken over a longer period, as shown clinical studies.[14,15].
Numerous reports on “Long Covid” give the impression that infection with SARS-CoV-2 in particular leads to long-term alterations in physical and mental health. However, a link between acute respiratory infection and chronic lung damage has been discussed for some time. For example, long-term complications such as recurrent obstructions and persistent hyperresponsiveness of the bronchial system have been described for bronchiolitis induced by respiratory syncytial virus (RSV).. RSV infection in infancy also increases asthma risk in young children, UK study shows. The need for antiviral agents with the broadest possible spectrum of activity is therefore still great. But since viruses are able to modify their genetic information in a short time and very quickly develop resistance to possible new therapies, researchers are faced with a difficult task.
The combination of nasturtium and horseradish has a triple effect and shortens the duration of the disease
It is worth taking a look at the plant kingdom here. For example, those belonging to the cruciferous genus (Brassicales) counting the anti-infective ingredients of nasturtium and horseradish herbal medicines – mustard oils – which have been shown to have a triple effect on colds such as acute bronchitis and sinusitis: against viruses[2-4] and bacteria[5-7] as well as an anti-inflammatory[8-13]. In vitro studies at the University of Gießen were able to prove that the combination of nasturtium and horseradish even inhibits the multiplication of the flu virus H1N1 in human lung cell cultures and can also fight other common cold viruses.
The efficacy and good tolerance of mustard oils in uncomplicated acute and recurrent respiratory infections have been proven in numerous clinical and epidemiological studies.[14,15,19,20]. A randomized, double-blind, placebo-controlled, multicenter study shows that typical symptoms of acute rhinosinusitis, such as anterior and posterior secretion, nasal congestion, and headache, improved two days faster when taking of the combination of plants than in the control group with placebo.. Another clinical study over a period of twelve weeks was also able to show that during the cold season, patients taking placebo tablets caught cold twice as often as patients in the verum group who received two tablets of the phytotherapeutic agent three times a day. day..
Avoid secondary infections, reduce the use of antibiotics
Although apparently almost always of viral origin, chemo-synthetic antibiotics are still used too often and often lightly for colds, which promotes increased bacterial resistance. “Therefore, phytopharmaceuticals such as nasturtium and horseradish mustard oil are the therapy of choice, especially in the early stages of inflammatory diseases of the airways,” says Hohmann. Due to the multimodal effects of mustard oils, the development of possible resistance mechanisms in bacteria is made much more difficult. The phytopharmaceutical derived from nasturtium and horseradish (ANGOCIN® Anti-infective N) is therefore suitable for the overall therapy of acute respiratory infections and helps to avoid secondary bacterial infections. “The combination of isothiocyanates is also a good option for slowing the spread of resistant germs and saving highly effective antibiotics for serious illnesses”, summarizes the expert.
ANGOCINA® anti-infective NOT
Application area: To improve the symptoms of acute inflammatory diseases of the bronchi, sinuses and urinary tract. Composition: 1 film-coated tablet contains: Nasturtium herb 200 mg, horseradish root 80 mg. Other ingredients: cellulose, iron oxides and hydroxides E 172, hypromellose, potato starch, macrogol, sodium carboxymethyl starch, colloidal anhydrous silicon dioxide, stearic acid, talc, titanium dioxide E 171. Contraindications: Acute gastric and intestinal ulcers and/or acute inflammation of the kidneys, allergy to nasturtium grass, horseradish root or any of the other ingredients. Side effects: Common: gastric and intestinal problems such as nausea, high abdominal pressure, diarrhoea, flatulence or heartburn. Uncommon: Systemic allergic reactions and skin hypersensitivity reactions (eg flushing, rash and/or itching). Pharmaceutical entrepreneur: Repha GmbH Biological Drugs, Alt-Godshorn 87, 30855 Langenhagen.
Sources 1-20 can be requested from the following press contact: